The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Burd S.G.

Federal Center of Brain Research and Neurotechnologies;
Pirogov Russian National Research Medical University (Pirogov University)

Lebedeva A.V.

Federal Center of Brain Research and Neurotechnologies;
Pirogov Russian National Research Medical University (Pirogov University);
Research Institute of Health Care Organization and Medical Management

Rubleva Yu.V.

Federal Center of Brain Research and Neurotechnologies

Efimenko A.P.

Federal Center of Brain Research and Neurotechnologies

Pantina N.V.

Federal Center of Brain Research and Neurotechnologies

Yurchenko A.V.

Federal Center of Brain Research and Neurotechnologies

Bogomazova M.A.

Federal Center of Brain Research and Neurotechnologies

Kovaleva I.I.

Federal Center of Brain Research and Neurotechnologies

Alekseeva G.A.

Federal Center of Brain Research and Neurotechnologies

Ototoxicity caused by anti-epileptic drugs

Authors:

Burd S.G., Lebedeva A.V., Rubleva Yu.V., Efimenko A.P., Pantina N.V., Yurchenko A.V., Bogomazova M.A., Kovaleva I.I., Alekseeva G.A.

More about the authors

Read: 1362 times


To cite this article:

Burd SG, Lebedeva AV, Rubleva YuV, et al. . Ototoxicity caused by anti-epileptic drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12):14‑19. (In Russ.)
https://doi.org/10.17116/jnevro202412412114

Recommended articles:
Personality profile caused by epilepsy acco­rding to the «Big Five» model. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):16-21
Abse­nce status epilepticus in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):47-56
A case of rare here­ditary Siddiqi syndrome with novel neuropsychiatric signs. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):171-176
Meniere’s disease and vestibular migraine: differential diagnostics and treatment. Russian Bulletin of Otorhinolaryngology. 2025;(1):57-63

References:

  1. Hamed SA, Sherifa A. The auditory and vestibular toxicities induced by antiepileptic drugs. Expert Opinion on Drug Safety. 2017;16(11):1281-1294. https://doi.org/10.1080/14740338.2017.1372420
  2. Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug discovery today 2005;10(19):1313-1321. https://doi.org/10.1016/S1359-6446(05)03552-X
  3. Burd SG, Bogomazova MA, Lebedeva AV, et al. Changes in the Bioelectric Activity of the Brain in Patients with Hearing Impairment. Otorhinolaryngology. Eastern Europe. 2022;12(2):212-218 (In Russ.). https://doi.org/10.34883/PI.2022.12.2.021
  4. LaPenna P, Laura MT. The pharmacology and toxicology of third-generation anticonvulsant drugs. Journal of Medical Toxicology. 2017;13:329-342.  https://doi.org/10.1007/s13181-017-0626-4
  5. Safdar A, Fatima I. A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid. Saudi Pharmaceutical Journal 2023;31(2): 265-278.  https://doi.org/10.1016/j.jsps.2022.12.001
  6. Armon C, Brown E, Carwile S, et al. Sensorineural hearing loss: a reversible effect of valproic acid. Neurology. 1990;40(12):1896-1896. https://doi.org/10.1212/wnl.40.12.1896
  7. Hori A, Kataoka S, Sakai K, et al. Valproic acid-induced hearing loss and tinnitus. Intern Medicine. 2003;42(11):1153-1154. https://doi.org/10.2169/internalmedicine.42.1153
  8. Incecik F, Akoglu E, Sangün O, et al. Effects of valproic acid on hearing in epileptic patients. International journal of pediatric otorhinolaryngology. 2007;71(4):611-6144. https://doi.org/10.1016/j.ijporl.2006.12.011
  9. Yeap LL, Lim KS, Lo YL, et al. Valproate-induced reversible sensorineural hearing loss: a case report with serial audiometry and pharmacokinetic modelling during a valproate rechallenge. Epileptic Disorders. 2014;16(3):375-379.  https://doi.org/10.1684/epd.2014.0671
  10. Stoorvogel M.S, Verhagen CVM, Verhagen WIM. Valproic Acid Induced Sensorineural Hearing Loss; a Case Report of Partially Reversible Hearing Loss In a Patient Treated With Valproic Acid. J Neurol Neuro Toxicol. 2018;2(1):001-003. 
  11. Papadeas E, Polychronopoulos P, Papathanasopoulos P, et al. Sensorineural hearing loss: a reversible effect of vigabatrin. Neurology. 2003;61(7):1020-1021. https://doi.org/10.1212/01.wnl.0000082396.01692.53
  12. Pierce DA, Holt SR, Reeves-Daniel A. A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. Clinical therapeutics. 2008;30(9):1681-1684. https://doi.org/10.1016/j.clinthera.2008.09.004
  13. de la Cruz M, Bance M. Carbamazepine-induced sensorineural hearing loss. Archives of Otolaryngology–Head and Neck Surgeru. 1999;125(2):225-227.  https://doi.org/10.1001/archotol.125.2.225
  14. Ahmad S. Diltiazem-carbamazepine interaction. Am Heart J. 1990;120(6):1485-1486. https://doi.org/10.1016/0002-8703(90)90283-4
  15. Tateno A, Morisawa K, Sawai K, Koya N. Three cases of partial epilepsy accompanied by hearing disorder during CBZ medication. Shonika Rinsho 1993;46:323-326. 
  16. Chaloupka V, Mitchell S, Muirhead R. Observation of a reversible, medication-induced change in pitch perception. The Journal of the Acoustical Society of America. 1994;96(1):145-149.  https://doi.org/10.1121/1.411437
  17. Miyaoka T, Seno H, Itoga M, et al. Reversible pitch perception deficit caused by carbamazepine. Clinical neuropharmacology. 2000;23(4):219-221.  https://doi.org/10.1097/00002826-200007000-00010
  18. Wakamoto H, Kume A, Nakano N. Elevated pitch perception owing to carbamazepine-activating effect on the peripheral auditory system: auditory brainstem response study. J Child Neurol. 2004;19(6):453-455.  https://doi.org/10.1177/088307380401900611
  19. Kobayashi T, Nisijima K, Ehara Y, et al. Pitch perception shift: a rare side-effect of carbamazepine. Psychiatry and clinical neurosciences. 2001;55(4):415-417.  https://doi.org/10.1046/j.1440-1819.2001.00883.x
  20. Tateno A, Sawada K, Takahashi I, et al. Carbamazepine-induced transient auditory pitch-perception deficit. Pediatric neurology. 2006;35(2):131-134.  https://doi.org/10.1016/j.pediatrneurol.2006.01.011
  21. Onodera M, Ogino T. A case report on auditory disturbance secondary to carbamazepine. Nippon Jibiinkouka Gakkai Kaihou 1994;97:562 
  22. Mabuchi K, Hayashi S, Nitta E, et al. Auditory disturbance induced by carbamazepine administration in a patient with secondary generalized seizure. Rinsho Shinkeigaku= Clinical Neurology. 1995;35(5):553-555. 
  23. Senzyo M. A case of psychogenic reaction, whose tone was flattened by carbamazepine. Seisin Igaku. 1995;37:649-651. 
  24. Nihei K, Naito Y. Two cases of absolute pitch perception caused by carbamazepine. J Jpn Epil Soc. 1997;15:68-69. 
  25. Yamamoto M, Wada K, Sakai K, Kugoh T. Auditory disturbance induced by carbamazepine. Epilepsia. 1997;38:132. 
  26. Kashihara K, Imai K, Shiro Y, et al. Reversible pitch perception deficit due to carbamazepine. Internal medicine. 1998;37(9):774-775.  https://doi.org/10.2169/internalmedicine.37.774
  27. Emori K. A case of complex partial seizure showing reversible semitone lowing during the elevation of CBZ blood concentration. J Jpn Epil Soc. 2000;18:71. 
  28. Watanabe T, Minagawa K, Nihira H, Ito N. Two cases of auditory disturbance due to carbamazepine. Tenkan Nituite. 2000;20:39-44. 
  29. Tateno A, Omura I. Two cases of auditory disturbance caused by carbamazepine. No to Hattatsu= Brain and Developmen. 2000;32(5):420-4233.
  30. Konno S. Half pitch lower sound perception caused by carbamazepine. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 2005;94(4):759-762.  https://doi.org/10.2169/naika.94.759
  31. Yoshikawa H, Abe T. Carbamazepine-induced abnormal pitch perception. Brain and Development. 2003;25(2):127-129.  https://doi.org/10.1016/s0387-7604(02)00155-9
  32. Fujimoto A, Enomoto T, Takano S, et al. Pitch perception abnormality as a side effect of carbamazepine. J Clin Neurosci. 2004;11(1):69-70.  https://doi.org/10.1016/s0967-5868(03)00068-7
  33. Braun M, Chaloupka V. Carbamazepine induced pitch shift and octave space representation. Hearing research. 2005;210(1-2):85-92.  https://doi.org/10.1016/j.heares.2005.05.015
  34. Gur-Ozmen S, Nirmalananthan N, von Oertzen TJ. Change of pitch due to carbamazepine and oxcarbazepine independently. Seizure. 2013;22(2):162-163.  https://doi.org/10.1016/j.seizure.2012.11.010
  35. Kawai M, Kanemoto K. A case of auditory disturbance caused by lacosamide. Epilepsy & Behavior Case Reports. 2019;11:70-72.  https://doi.org/10.1016/j.ebcr.2018.12.001

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.